Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy (CAREFOR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01819233 |
Recruitment Status :
Completed
First Posted : March 27, 2013
Results First Posted : December 23, 2019
Last Update Posted : December 23, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: N/A; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment |
Conditions |
Ductal Breast Carcinoma in Situ Invasive Ductal Breast Carcinoma Invasive Lobular Breast Carcinoma Lobular Breast Carcinoma in Situ Recurrent Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer |
Interventions |
Behavioral: Behavioral dietary intervention Procedure: Therapeutic conventional surgery Radiation: Radiation therapy Other: Counseling intervention Procedure: Quality-of-life assessment |
Enrollment | 38 |
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Behavioral Dietary Intervention |
---|---|
![]() |
Beginning 2-4 weeks after completion of lumpectomy, patients receive food diaries to complete for 7-10 days. Dietary counselors then give patients guidelines for dietary modifications to reduce caloric intake by 25% of their normal diet. Patients follow caloric restricted diet for 10 weeks (2 weeks prior to radiation therapy, during 6 weeks of radiation therapy, and at least 2 weeks after radiation therapy). Patients undergo radiation therapy QD 5 days a week for 6 weeks. Behavioral dietary intervention: Receive caloric restricted dietary intervention Therapeutic conventional surgery: Undergo definitive lumpectomy Radiation therapy: Undergo radiation therapy Counseling intervention: Receive dietary counseling Quality-of-life assessment: Ancillary studies |
Period Title: Overall Study | |
Started | 38 |
Completed | 32 |
Not Completed | 6 |
Arm/Group Title | Behavioral Dietary Intervention | |
---|---|---|
![]() |
Beginning 2-4 weeks after completion of lumpectomy, patients receive food diaries to complete for 7-10 days. Dietary counselors then give patients guidelines for dietary modifications to reduce caloric intake by 25% of their normal diet. Patients follow caloric restricted diet for 10 weeks (2 weeks prior to radiation therapy, during 6 weeks of radiation therapy, and at least 2 weeks after radiation therapy). Patients undergo radiation therapy QD 5 days a week for 6 weeks. Behavioral dietary intervention: Receive caloric restricted dietary intervention Therapeutic conventional surgery: Undergo definitive lumpectomy Radiation therapy: Undergo radiation therapy Counseling intervention: Receive dietary counseling Quality-of-life assessment: Ancillary studies |
|
Overall Number of Baseline Participants | 38 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 38 participants | |
<=18 years |
0 0.0%
|
|
Between 18 and 65 years |
33 86.8%
|
|
>=65 years |
5 13.2%
|
|
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 38 participants | |
Female |
38 100.0%
|
|
Male |
0 0.0%
|
|
Ethnicity (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 38 participants | |
Hispanic or Latino |
4 10.5%
|
|
Not Hispanic or Latino |
33 86.8%
|
|
Unknown or Not Reported |
1 2.6%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 38 participants | |
American Indian or Alaska Native |
0 0.0%
|
|
Asian |
1 2.6%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
|
Black or African American |
15 39.5%
|
|
White |
18 47.4%
|
|
More than one race |
0 0.0%
|
|
Unknown or Not Reported |
4 10.5%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||
United States | Number Analyzed | 38 participants |
38 |
Name/Title: | Dr. Nicole Simone |
Organization: | Sidney Kimmel Cancer Center at Thomas Jefferson University |
Phone: | 215-955-6702 |
EMail: | nicole.simone@jefferson.edu |
Responsible Party: | Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University ) |
ClinicalTrials.gov Identifier: | NCT01819233 |
Other Study ID Numbers: |
12G.616 2012-94 ( Other Identifier: CCRRC ) |
First Submitted: | March 22, 2013 |
First Posted: | March 27, 2013 |
Results First Submitted: | October 29, 2019 |
Results First Posted: | December 23, 2019 |
Last Update Posted: | December 23, 2019 |